Tumour differentiation grade is associated with TNM staging and the risk of node metastasis in colorectal cancer

Abstract Aim. The tumour differentiation grade has been shown by numerous multivariate analyses to be a stage-independent prognostic factor in colorectal cancer. The aim of this study was to explore the importance of differentiation grading for the staging of colorectal cancer and how it relates to the components of the TNM system. Material and methods. The study was a retrospective single-centre analysis of all patients undergoing surgical resection for colorectal cancer during the period 2002–2007 (n = 1239). The clinical parameters and pathology data of overall stage, differentiation grade, local tumour (T)-stage and metastasis status (M-stage) were included as well as the lymph node count of both assessed and metastatic nodes. The differentiation grade was correlated with demography, overall stage and each component of the TNM staging system. The correlation between differentiation grade and N-stage was also explored for the separate T-stages. Results. The tumour differentiation grade correlated significantly with the overall TNM stage (p < 0.0001). The grade significantly correlated with the T-stage and the risk of having lymph node metastasis (p < 0.0001). A high grade was associated with a higher positive lymph node count in stage III disease (p < 0.0002). For the T-stages, the risk of node metastasis was significantly linked to the tumour grade. A low grade (G1) T2 had a 17% risk of lymph node metastasis compared to a 44% risk for a high grade (G4) T2. Conclusion. Tumour differentiation is an important prognostic factor. It correlates significantly with the overall stage of the TNM system and also to each of its components. The risk of having lymph node metastasis for each T-stage also correlates with the tumour grade. The findings can be of importance in postoperative risk assessment or when considering local resection procedures like TEM.

[1]  R J Salmon,et al.  [Prognostic factors of colorectal cancer]. , 1989, Pathologie-biologie.

[2]  C. Ratto,et al.  Prognostic factors in colorectal cancer , 1998, Diseases of the colon and rectum.

[3]  J. Guillem,et al.  All patients with small intramural rectal cancers are at risk for lymph node metastasis , 1999, Diseases of the colon and rectum.

[4]  M E Hammond,et al.  Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. , 2000, Archives of pathology & laboratory medicine.

[5]  L. Burgart,et al.  Risk of Lymph Node Metastasis in T1 Carcinoma of the Colon and Rectum , 2002, Diseases of the colon and rectum.

[6]  C. Compton.  Colorectal Carcinoma: Diagnostic, Prognostic, and Molecular Features , 2003, Modern Pathology.

[7]  C. Compton.  Surgical pathology for the oncology patient in the age of standardization: of margins, micrometastasis, and molecular markers. , 2003, Seminars in radiation oncology.

[8]  L. Burgart,et al.  Long-Term Survival After Local Excision for T1 Carcinoma of the Rectum , 2004, Diseases of the colon and rectum.

[9]  H. Baba,et al.  The risk of lymph node metastasis in T1 colorectal carcinoma. , 2004, Hepato-gastroenterology.

[10]  T. Saclarides.  Transanal endoscopic microsurgery. , 1997, Seminars in laparoscopic surgery.

[11]  Adjuvant chemotherapy in colorectal cancer: A joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group , 2005 .

[12]  Shung-Haur Yang,et al.  Metastatic potential in T1 and T2 colorectal cancer. , 2005, Hepato-gastroenterology.

[13]  C. Ko,et al.  A 10-Year Outcomes Evaluation of Mucinous and Signet-Ring Cell Carcinoma of the Colon and Rectum , 2005, Diseases of the colon and rectum.

[14]  H. Grönberg,et al.  Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group. , 2003, Acta oncologica.

[15]  Y. Ohashi,et al.  Significance of Histologic Type of Primary Lesion and Metastatic Lymph Nodes as a Prognostic Factor in Stage III Colon Cancer , 2006, Diseases of the colon and rectum.

[16]  V. Khatri,et al.  Staging and prognosis of colon cancer. , 2006, Surgical oncology clinics of North America.

[17]  P. Loehrer.  Colon Cancer Survival Rates With the New American Joint Committee on Cancer Sixth Edition Staging , 2006 .

[18]  C. Compton.  Optimal Pathologic Staging: Defining Stage II Disease , 2007, Clinical Cancer Research.

[19]  J. Jass.  Classification of colorectal cancer based on correlation of clinical, morphological and molecular features , 2007, Histopathology.

[20]  J. Guillem,et al.  Lymph node metastasis in T1 adenocarcinoma of the colon and rectum , 2004, Journal of Gastrointestinal Surgery.

[21]  G. Carlsson,et al.  Stage migration in colorectal cancer related to improved lymph node assessment. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[22]  J. Kim,et al.  Risk Factors for Lymph Node Metastasis in Submucosal Invasive Colorectal Cancer , 2008, World Journal of Surgery.

[23]  J. Jass,et al.  Node-Negative Colorectal Cancer at High Risk of Distant Metastasis Identified by Combined Analysis of Lymph Node Status, Vascular Invasion, and Raf-1 Kinase Inhibitor Protein Expression , 2008, Clinical Cancer Research.

[24]  G. Carlsson,et al.  A study of lymph node ratio as a prognostic marker in colon cancer. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[25]  T. Saclarides,et al.  Transanal endoscopic microsurgery. , 2008, Minerva chirurgica.

[26]  G. Baatrup,et al.  Preoperative staging and treatment options in T1 rectal adenocarcinoma , 2009, Acta oncologica.

[27]  J. O’Sullivan,et al.  Tumor Budding is a Strong and Reproducible Prognostic Marker in T3N0 Colorectal Cancer , 2009, The American journal of surgical pathology.

[28]  R. Tollenaar,et al.  Is the increasing role of Transanal Endoscopic Microsurgery in curation for T1 rectal cancer justified? A systematic review , 2009, Acta oncologica.